Sustained Remission of Lupus Panniculitis Treated With Hydroxychloroquine in a Patient With Crohn’s Disease: A Case Report

Extraintestinal manifestations (EIM) in inflammatory bowel disease (IBD) are common including cutaneous manifestations that either precede or follow manifestations of IBD. Cutaneous manifestations of IBD include erythema nodosum, pyoderma gangrenosum, oral lesions, and Sweet’s syndrome. Cutaneous ma...

Full description

Saved in:
Bibliographic Details
Published in:Curēus (Palo Alto, CA) CA), 2020-09, Vol.12 (9)
Main Authors: Zheng, David D, Mantis, Jazila, Gurung, Dawa O, Abrudescu, Adriana
Format: Article
Language:English
Subjects:
Bacterial infections
Case reports
Colonoscopy
Erythema
Gastroenterology
Hospitals
Infections
Inflammation
Inflammatory bowel disease
Internal Medicine
Lupus
Medicine
Neutropenia
Patients
Remission (Medicine)
Rheumatology
Steroids
Tumor necrosis factor-TNF
Ulcers
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Extraintestinal manifestations (EIM) in inflammatory bowel disease (IBD) are common including cutaneous manifestations that either precede or follow manifestations of IBD. Cutaneous manifestations of IBD include erythema nodosum, pyoderma gangrenosum, oral lesions, and Sweet’s syndrome. Cutaneous manifestations of IBD tend to recur and extensive cases may require maintenance management with immunomodulators or biologics. However, the complications and adverse effects of long-term therapy with immunosuppressive agents are numerous and need to be considered before their initiation. We report a case of a Crohn’s disease patient with recurrent and debilitating cutaneous manifestation of lupus panniculitis that had sustained remission with hydroxychloroquine.
ISSN:2168-8184
2168-8184
DOI:10.7759/cureus.10455